Trial intelligence / Profile preview

Kinetics of BG Assay with Voriconazole

NCT00904995Phase 3Completed

Sponsor
University of Texas MD Anderson Cancer Center
Start
May 2009
Primary completion
Jul 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of voriconazole in fungal infection, sponsored by University of Texas MD Anderson Cancer Center. Started May 2009; status: completed.

02

Drugs

voriconazole
03

Conditions

fungal infection

Beyond the preview

Go deeper on NCT00904995.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00904995.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call